Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue Sarcoma
- Conditions
- Soft Tissue Sarcoma
- Interventions
- First Posted Date
- 2019-10-15
- Last Posted Date
- 2019-10-15
- Target Recruit Count
- 120
- Registration Number
- NCT04126811
- Locations
- 🇨🇳
Tianjin Medical University Cancer Hospital & Institute, Tianjin, Tianjin, China
Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma
- First Posted Date
- 2019-10-15
- Last Posted Date
- 2019-10-15
- Target Recruit Count
- 80
- Registration Number
- NCT04126993
- Locations
- 🇨🇳
Tianjin Medical University Cancer Hospital & Institute, Tianjin, Tianjin, China
Ear Acupuncture Preventing Delayed Gastric Emptying.
- Conditions
- Auricular Acupoint EmbeddingPancreaticoduodenectomyDelayed Gastric Emptying
- Interventions
- Other: Ear Acupuncture
- First Posted Date
- 2019-10-08
- Last Posted Date
- 2019-10-08
- Target Recruit Count
- 180
- Registration Number
- NCT04118881
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
A Trial of Total Versus Partial Omentectomy for Advanced Gastric Cancer in Gastrectomy
- Conditions
- Gastric Cancer
- Interventions
- Procedure: Type of omentectomy
- First Posted Date
- 2019-09-30
- Last Posted Date
- 2019-09-30
- Target Recruit Count
- 418
- Registration Number
- NCT04108494
- Locations
- 🇨🇳
Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China
Radiomics of Immunotherapeutics Response Evaluation and Prediction
- Conditions
- Predictive Cancer ModelSolid Tumor
- Interventions
- Diagnostic Test: ClinicalDiagnostic Test: SemanticDiagnostic Test: Radiomic
- First Posted Date
- 2019-09-06
- Last Posted Date
- 2020-04-02
- Target Recruit Count
- 285
- Registration Number
- NCT04079283
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute And Hospital, Tianjin, Tianjin, China
Phase 2 Study of Pyrotinib in Previously Treated Patients With NSCLC Having EGFR or ERBB2 Exon 20 Insertion Mutation
- First Posted Date
- 2019-08-21
- Last Posted Date
- 2019-08-21
- Target Recruit Count
- 60
- Registration Number
- NCT04063462
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
Study of Anlotinib Combined With Osimertinib as Second-line Treatment in Stage IIIb-IV NSCLC With Confirmed EGFRm and T790M
- First Posted Date
- 2019-07-23
- Last Posted Date
- 2019-08-21
- Target Recruit Count
- 53
- Registration Number
- NCT04029350
- Locations
- 🇨🇳
Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China
🇨🇳Shanxi Provincal Cancer Hospital, Taiyuan, Shanxi, China
🇨🇳Hebei Provincial People's Hospital, Shijiazhuang, Hebei, China
Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.
- First Posted Date
- 2019-06-20
- Last Posted Date
- 2019-06-20
- Target Recruit Count
- 70
- Registration Number
- NCT03992885
- Locations
- 🇨🇳
Department of Pulmonary Medical Oncology, Tianjin Medical University Cancer Hospital, Tianjin, Tianjin, China
Methods of Computed Tomography Screening and Management of Lung Cancer
- Conditions
- Lung NeoplasmsComputed TomographyLung NodulesMass Screening
- Interventions
- Other: lung cancer screening
- First Posted Date
- 2019-06-20
- Last Posted Date
- 2019-06-20
- Target Recruit Count
- 4000
- Registration Number
- NCT03992833
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute And Hospital, Tianjin, Tianjin, China
Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma
- Conditions
- Clear Cell Renal Cell CarcinomaRenal Cell Carcinoma
- Interventions
- Biological: SHR-1210Biological: CIK cells
- First Posted Date
- 2019-06-17
- Last Posted Date
- 2020-07-07
- Target Recruit Count
- 90
- Registration Number
- NCT03987698
- Locations
- 🇨🇳
Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China